About David Hanaman
Form D filings for Curavit Clinical Research from 2022 to 2024 list David Hanaman as director.
David Hanaman first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name David Hanaman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Hanaman works with at each company, as listed on that company's latest Form D.
Curavit Clinical Research Corp · Form D/A, Sep 5, 2024
JK
Jackie Kent
Director
RL
Rich Lester
Director
JM
Joel Morse
Chief Executive Officer and director
NL
Nathanael Lentz
Director